Labeler
Novartis Pharmaceuticals Corporation NDC Codes
Novartis Pharmaceuticals Corporation lists 165 finished drug products in the FDA NDC Directory under NDC labeler code 0078.
Overview
Each product below links to its own NDC page with package NDCs in 10- and 11-digit form.
- Drugs
- Entresto, Promacta, Jadenu, Exforge HCT, Vijoice, Cosentyx, Afinitor, Zortress, Tafinlar, Mekinist, Scemblix, Piqray, Mayzent, Kisqali, Sandostatin LAR Depot
- Active ingredients
- Valsartan, Everolimus, Sacubitril, Eltrombopag olamine, Deferasirox, Amlodipine besylate, Alpelisib, Hydrochlorothiazide, Secukinumab, Dabrafenib mesylate, Trametinib dimethyl sulfoxide, Asciminib hydrochloride
- NDC labeler codes
- 0078
- Strengths (from the 100 most recently listed products)
- Valsartan 160 mg/1; Amlodipine besylate 10 mg/1; Ribociclib succinate 200 mg/1; Hydrochlorothiazide 25 mg/1; Alpelisib 50 mg/1; Eltrombopag olamine 25 mg/1; Eltrombopag olamine 12.5 mg/1; Deferasirox 180 mg/1; Deferasirox 360 mg/1; Deferasirox 90 mg/1; Sacubitril 49 mg/1; Valsartan 51 mg/1; Sacubitril 24 mg/1; Valsartan 26 mg/1; Imatinib mesylate 400 mg/1; Everolimus 5 mg/1; Amlodipine besylate 5 mg/1; Hydrochlorothiazide 12.5 mg/1; Remibrutinib 25 mg/1; Atrasentan hydrochloride .75 mg/1
- Dosage forms
- Tablet, Film coated, Tablet, Capsule, Kit, Injection, Solution, Injection, Granule, Tablet, For suspension, Injection, Suspension, Patch, Extended release, Pellet, Injection, Powder, Lyophilized, For solution, Powder, For suspension, Injection, Solution, Concentrate, Powder, For solution, Capsule, Liquid filled, Solution/ drops, Suspension/ drops
- Routes
- Oral, Intravenous, Subcutaneous, Ophthalmic, Transdermal, Intravitreal
- Drug classes (FDA established)
- Kinase Inhibitor, Angiotensin 2 Receptor Blocker, mTOR Inhibitor Immunosuppressant, Neprilysin Inhibitor, Thrombopoietin Receptor Agonist, Iron Chelator, Calcium Channel Blocker, Dihydropyridine Calcium Channel Blocker, Sphingosine 1-phosphate Receptor Modulator, Thiazide Diuretic, Interleukin-17A Antagonist, Cholinesterase Inhibitor, CD19-directed Chimeric Antigen Receptor, Genetically-modified Autologous T Cells, Antimalarial, Endothelin Receptor Antagonist, Corticosteroid, Complement Factor B Inhibitor, Radioligand Therapeutic Agent, Selectin Blocker, Anthelmintic, Topoisomerase Inhibitor, Nucleoside Metabolic Inhibitor, Lymphocyte Function-Associated Antigen-1 Antagonist, Nonsteroidal Anti-inflammatory Drug, CD20-directed Cytolytic Antibody
- HCPCS / J-code
- None in Med-Code's directory for these products
- Package NDCs
- 136 (from the 100 most recently listed products)
NDC codes
Newest listings first. Each row links to the product’s NDC page.
| Product | Strength | Form · route | Product NDC | Package NDCs (11-digit) | HCPCS |
|---|---|---|---|---|---|
| Exforgeamlodipine besylate and valsartan | Amlodipine besylate 5 mg/1; Valsartan 320 mg/1 | Tablet, Film coatedOral | 0078-0490 | 00078-0490-15 | — |
| Exforgeamlodipine besylate and valsartan | Amlodipine besylate 10 mg/1; Valsartan 320 mg/1 | Tablet, Film coatedOral | 0078-0491 | 00078-0491-15 | — |
| Exforgeamlodipine besylate and valsartan | Amlodipine besylate 5 mg/1; Valsartan 160 mg/1 | Tablet, Film coatedOral | 0078-0488 | 00078-0488-15 | — |
| Travatan Ztravoprost | Travoprost .04 mg/mL | Solution/ dropsOphthalmic | 0078-0946 | 00078-0946-40 | — |
| Diovan HCTvalsartan and hydrochlorothiazide | Valsartan 320 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 0078-0472 | 00078-0472-34 | — |
| Diovan HCTvalsartan and hydrochlorothiazide | Valsartan 320 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 0078-0471 | 00078-0471-34 | — |
| Exjadedeferasirox | Deferasirox 250 mg/1 | Tablet, For suspensionOral | 0078-0469 | 00078-0469-15 | — |
| Exjadedeferasirox | Deferasirox 500 mg/1 | Tablet, For suspensionOral | 0078-0470 | 00078-0470-15 | — |
| Exjadedeferasirox | Deferasirox 125 mg/1 | Tablet, For suspensionOral | 0078-0468 | 00078-0468-15 | — |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | 0078-0432 | 00078-0432-05 | — |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 25 mg/1 | Capsule, Extended releaseOral | 0078-0608 | — | — |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 15 mg/1 | Capsule, Extended releaseOral | 0078-0493 | — | — |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | 0078-0433 | 00078-0433-05 | — |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 5 mg/1 | Capsule, Extended releaseOral | 0078-0430 | — | — |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 35 mg/1 | Capsule, Extended releaseOral | 0078-0609 | — | — |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | 0078-0431 | — | — |
| Focalin XRdexmethylphenidate hydrochloride | Dexmethylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | 0078-0434 | — | — |
| Myforticmycophenolic acid | Mycophenolate sodium 360 mg/1 | Tablet, Delayed releaseOral | 0078-0386 | 00078-0386-66 | — |
| Myforticmycophenolic acid | Mycophenolate sodium 180 mg/1 | Tablet, Delayed releaseOral | 0078-0385 | 00078-0385-66 | — |
| Ritalin LAmethylphenidate hydrochloride | Methylphenidate hydrochloride 30 mg/1 | Capsule, Extended releaseOral | 0078-0371 | 00078-0371-05 | — |
| Ritalin LAmethylphenidate hydrochloride | Methylphenidate hydrochloride 40 mg/1 | Capsule, Extended releaseOral | 0078-0372 | 00078-0372-05 | — |
| Ritalin LAmethylphenidate hydrochloride | Methylphenidate hydrochloride 10 mg/1 | Capsule, Extended releaseOral | 0078-0424 | 00078-0424-05 | — |
| Ritalin LAmethylphenidate hydrochloride | Methylphenidate hydrochloride 20 mg/1 | Capsule, Extended releaseOral | 0078-0370 | 00078-0370-05 | — |
| Diovanvalsartan | Valsartan 80 mg/1 | TabletOral | 0078-0358 | 00078-0358-34 | — |
| Diovanvalsartan | Valsartan 40 mg/1 | TabletOral | 0078-0423 | 00078-0423-15 | — |
| Diovanvalsartan | Valsartan 160 mg/1 | TabletOral | 0078-0359 | 00078-0359-34 | — |
| Diovanvalsartan | Valsartan 80 mg/1 | TabletOral | 0078-1245 | 00078-1245-34 | — |
| Diovanvalsartan | Valsartan 160 mg/1 | TabletOral | 0078-1252 | 00078-1252-34 | — |
| Diovanvalsartan | Valsartan 320 mg/1 | TabletOral | 0078-1259 | 00078-1259-34 | — |
| Diovanvalsartan | Valsartan 320 mg/1 | TabletOral | 0078-0360 | 00078-0360-34 | — |
| Trileptaloxcarbazepine | Oxcarbazepine 60 mg/mL | SuspensionOral | 0078-0357 | 00078-0357-52 | — |
| Gleevecimatinib mesylate | Imatinib mesylate 100 mg/1 | TabletOral | 0078-0401 | 00078-0401-34 | — |
| Trileptaloxcarbazepine | Oxcarbazepine 300 mg/1 | Tablet, Film coatedOral | 0078-0337 | 00078-0337-0500078-0337-06 | — |
| Trileptaloxcarbazepine | Oxcarbazepine 150 mg/1 | Tablet, Film coatedOral | 0078-0456 | 00078-0456-0500078-0456-35 | — |
| Trileptaloxcarbazepine | Oxcarbazepine 600 mg/1 | Tablet, Film coatedOral | 0078-0457 | 00078-0457-0500078-0457-35 | — |
| Simulectbasiliximab | Basiliximab 20 mg/5mL | Injection, Powder, For solutionIntravenous | 0078-0331 | 00078-0331-84 | — |
| Simulectbasiliximab | Basiliximab 10 mg/2.5mL | Injection, Powder, For solutionIntravenous | 0078-0393 | 00078-0393-61 | — |
| Diovan HCTvalsartan and hydrochlorothiazide | Valsartan 160 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 0078-0315 | 00078-0315-34 | — |
| Diovan HCTvalsartan and hydrochlorothiazide | Valsartan 160 mg/1; Hydrochlorothiazide 25 mg/1 | Tablet, Film coatedOral | 0078-0383 | 00078-0383-34 | — |
| Diovan HCTvalsartan and hydrochlorothiazide | Valsartan 80 mg/1; Hydrochlorothiazide 12.5 mg/1 | Tablet, Film coatedOral | 0078-0314 | 00078-0314-34 | — |
| Femaraletrozole | Letrozole 2.5 mg/1 | Tablet, Film coatedOral | 0078-0249 | 00078-0249-15 | — |
| Tegretol XRcarbamazepine | Carbamazepine 100 mg/1 | Tablet, Extended releaseOral | 0078-0510 | 00078-0510-05 | — |
| Tegretol XRcarbamazepine | Carbamazepine 200 mg/1 | Tablet, Extended releaseOral | 0078-0511 | 00078-0511-05 | — |
| Tegretol XRcarbamazepine | Carbamazepine 400 mg/1 | Tablet, Extended releaseOral | 0078-0512 | 00078-0512-05 | — |
| Betoptic Sbetaxolol hydrochloride | Betaxolol hydrochloride 2.8 mg/mL | Suspension/ dropsOphthalmic | 0078-0729 | 00078-0729-1000078-0729-15 | — |
| Neoralcyclosporine | Cyclosporine 25 mg/1 | Capsule, Liquid filledOral | 0078-0246 | 00078-0246-15 | — |
| Neoralcyclosporine | Cyclosporine 100 mg/mL | SolutionOral | 0078-0274 | 00078-0274-22 | — |
| Neoralcyclosporine | Cyclosporine 100 mg/1 | Capsule, Liquid filledOral | 0078-0248 | 00078-0248-15 | — |
| Lotrelamlodipine besylate and benazepril hydrochloride | Amlodipine besylate 10 mg/1; Benazepril hydrochloride 40 mg/1 | CapsuleOral | 0078-0379 | — | — |
| Lotrelamlodipine besylate and benazepril hydrochloride | Amlodipine besylate 5 mg/1; Benazepril hydrochloride 20 mg/1 | CapsuleOral | 0078-0406 | — | — |
Novartis Pharmaceuticals Corporation: common questions
- What is Novartis Pharmaceuticals Corporation's NDC labeler code?
- 0078. The labeler code is the first segment of each NDC. About labeler codes.
- Is there a J-code for Novartis Pharmaceuticals Corporation?
- Med-Code's curated HCPCS directory has no drug-specific code for these products. Drugs dispensed by a pharmacy are billed by NDC. NDC vs J-code.
- Which NDC goes on a claim?
- The package NDC of what was given, in 11-digit form. How to convert a 10-digit NDC.